Navigation Links
Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
Date:3/10/2008

- Multiple Studies Presented at Society of Gynecologic Oncologists' Annual

Meeting on Women's Cancer -

FREMONT, Calif. and TAMPA, Fla., March 10 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRMLD), a molecular diagnostics company, presented data from several studies demonstrating the benefits of the Company's ovarian cancer protein biomarker panel. The data suggest that use of Vermillion's biomarkers could help better identify women with ovarian cancer, as well as improve the detection of early-stage disease. Results of these studies were presented at the Society of Gynecologic Oncologists' (SGO) 39th Annual Meeting on Women's Cancer in Tampa, Florida (Posters 080, 135, 175).

"The data presented today continue to confirm the potential of our biomarkers to distinguish between benign and malignant tumors and diagnose early-stage disease," said Eric T. Fung, M.D., Ph.D., Chief Scientific Officer of Vermillion.

Further Evidence Supporting Ovarian Tumor Triage Test (Poster 135)

A clinical study examining Vermillion's marker panel for ovarian cancer provided independent validation that it can distinguish malignant tumors from benign pelvic masses. Results of the study demonstrated that the biomarker panel could more than double the number of ovarian cancer cases referred to a gynecologic oncologist, thereby improving survival rates and reducing the number of surgeries performed.

A model comprising the Company's biomarker panel was trained on a set of 270 samples from the University of Kentucky. This model was then tested in a prospectively collected cohort of 709 women from Rigshospitalet in Copenhagen, Denmark. Vermillion's model demonstrated portability from the training set to
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
2. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
3. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
4. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
9. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
10. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
11. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015  Vanda Pharmaceuticals Inc. (Vanda) ... results of the Phase II proof of concept ... tradipitant as a monotherapy in the treatment of ... a highly significant and clinically meaningful improvement from ... as measured on a 100mm unit Visual Analog ...
(Date:3/4/2015)... , March 4, 2015 Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that ... ring The Opening Bell ® of the New ... Asterias began trading as an NYSE MKT listed company ... Stock Exchange is a trusted partner to Asterias Biotherapeutics, ...
(Date:3/4/2015)... 2015 InfuSystem Holdings, Inc. (NYSE MKT: INFU), ... services for the U.S. healthcare industry, today announced that ... financial results on Monday, March 9, 2015 after the ... a conference call for investors on Monday, March 9, ... quarter and full year 2014 performance and results.  To ...
Breaking Medicine Technology:Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3
... , , HOUSTON , Jan. ... Sales at eCardio, died peacefully in his home on ... was 53. , Woodyard began his tenure at eCardio ... led the company,s sales development initiatives. He was also responsible ...
... New contract gives U.S. Naval hospitals access to ECRI Institute,s ... PLYMOUTH MEETING, Pa. , Jan. 25 ... best approaches to improving patient care, announces a new contract, ... its comprehensive advisory service for managing medical equipment procurement, maintenance, ...
Cached Medicine Technology:Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer 2ECRI Institute Awarded U.S. Navy Contract for Health Technology Services 2ECRI Institute Awarded U.S. Navy Contract for Health Technology Services 3ECRI Institute Awarded U.S. Navy Contract for Health Technology Services 4
(Date:3/4/2015)... 04, 2015 FDA’s New Inspection Approach:, ... Webinar**, March 24, 2015 — 1:30 p.m. – 3:00 ... know within four hours of an inspection whether a ... on their “good” list, they’ll merely ask for reassurance ... is on the “bad” list, the manufacturer must get ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
(Date:3/4/2015)... New York, New York (PRWEB) March 04, 2015 ... it was reviewing the cardiovascular risks potentially associated with ... & Drug Administration (FDA) announced that it will now ... medications may increase their risk for heart attacks and ... March 3, 2015, the agency also stated that it ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Alliance Healthcare ... and wellness for those in need in San Diego ... local organizations through its Mission Support Grants program with ... non-profit organizations applied for AHF’s Mission Support Grants program. ... AHF’s board of trustees and program committee, as well ...
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2
... Centers To Provide Former Clients With ... Weight Loss ... of "helping,their clients find solutions," Pure Weight Loss has been pursuing,agreements ... former Pure Weight Loss clients at no additional, or,reduced, charges. Currently, ...
... might be best course, study finds , , FRIDAY, Jan. 4 ... at home is as safe and effective as hospital care, ... children under the age of 5 each year. However, antibiotics ... , "Severe in pneumonia in children can be safely ...
... 4 RxElite, Inc. (OTC,Bulletin Board: RXEI), ... prescription drug products, announced today the suspension ... 53,747,555 shares. The,suspension is permitted by the ... company requested this suspension to protect investors,due ...
... Can Access State,s Program; ... Uninsured, NEW YORK, Jan. 4 On January 8, ... Komen for the Cure will join,breast cancer survivors, health experts ... revealing report describing gaps in,New York,s public health policies. These ...
... initial sips typically happen in the home or at church, ... out of five American children between the ages of 8 ... a new study shows. , However, one in three ... their youngster had done so, the researchers noted. , The ...
... 4 Beginning in January,Sharing Miracles -- a ... features compelling and inspirational stories told by,patients -- ... around the country., Hosted by former Congressman ... CEO of the Pharmaceutical Research and Manufacturers of,America ...
Cached Medicine News:Health News:Pure Weight Loss Takes Additional Steps To Assure Seamless Transition For Clients 2Health News:Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries 2Health News:RxElite Registration Statement Suspended 2Health News:Susan G. Komen for the Cure, Ryan Community Health Centers, Breast Cancer Survivors Call on New York State to Expand Breast Cancer Screening, Treatment Programs 2Health News:Almost Half of 10-Year-Olds Have Tasted Alcohol 2Health News:'Sharing Miracles' Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow 2Health News:'Sharing Miracles' Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow 3
Commode chair....
... years experience in the field of Urodynamics, Albyn ... Chair. Our new chair is manufactured from the ... Urodynamic studies can be improved considerably if the ... test, and this aspect was given a high ...
... 6202 is the ultimate in ... most popular accessories, the 6202 ... myriad of exam and treatment ... motors allow fast & precise ...
The Triage Drugs of Abuse Panel is the leading rapid drug screen used by U.S. hospitals. The Triage Drugs of Abuse Panel is a small, handheld urine test that provides qualitative results for up to n...
Medicine Products: